From Screen to Airway: How CAD and 3D Simulation Are Rewriting the Respiratory Device Playbook

A poorly fitting airway stent can kink, migrate, or provoke tissue growth that lands a patient back in the bronchoscopy suite within weeks. Until recently, that risk was the cost of working from a short catalog of stock sizes. Every respiratory device that touches a patient carries the same exposure: miss the geometry or the flow field, and the fallout shows up at the bedside, not on the CAD screen.

That is why the design pipeline for ventilators, nebulizers, masks, and stents has tilted so hard toward CAD-driven modeling and 3D simulation. The interesting part for clinicians is how much of that pipeline now shapes what ends up in a patient’s hand, and how much of it they can reasonably ask about before they use it.

It Starts With a Patient-Shaped Model, Not a Catalog Part

The old design loop started with an average airway, an average face, an average tidal volume. Engineers drew to a spec sheet and hoped the anatomy on the other end cooperated. The new loop starts with a CT scan or a high-resolution surface capture, pulled straight into CAD as a patient-specific geometry.

That shift matters because respiratory anatomy punishes averages. Two tracheas of the same length can differ sharply in cross-section, angle at the carina, and degree of malacia. When the starting geometry is the patient’s own, everything downstream inherits that reality: wall thickness, flange placement, aerosol targeting.

Simulation Replaces Guesswork on Flow and Deposition

Once the model exists, computational fluid dynamics does the heavy lifting. A peer-reviewed review of CFD in respiratory drug delivery walks through how simulation is used to study aerosol formation, device performance, and complete-airway deposition, including where a metered-dose inhaler’s plume actually lands. A bench rig can only approximate that.

For ventilator circuits and interface masks, similar techniques predict pressure drops, leak paths, and dead-space behavior long before a prototype is molded. Designers can sweep dozens of variants overnight and keep the two or three worth printing. Bench work still happens, on fewer and better candidates.

Credibility Is Earned Before the Regulator Asks

A pretty simulation is not evidence. Regulators want to know how much a given model can be trusted for the specific decision it is supporting, and that question now has a shared vocabulary.

The 2024 FDA/MDIC Symposium summary lays out how computational modeling and simulation supports development, evaluation, and authorization of medical devices, leaning on the ASME V&V 40–2018 standard and FDA credibility guidance to frame model credibility across the total product lifecycle.

Put plainly: the higher the risk of the decision the model informs, the more verification and validation the manufacturer has to show. A model used to rank early concepts needs less rigor than one used to justify skipping a benchtop test. Clinicians rarely see the paperwork, but it is the reason a simulated result can carry any weight in a submission.

From Screen to Print to Bedside

The tightest loop between CAD and the patient sits in interventional pulmonology. Patient-specific airway stents built from CT-derived models were first implanted under FDA compassionate use, and full clearance in 2019 opened them to broader clinical use. A recent case series on 3D-printed stents in non-stenotic airways reports novel uses well beyond the original indications, including extrinsic vascular compression and bronchopleural fistula from airway dehiscence.

Those cases describe a workflow, not a gadget. Scan the airway, segment it in software, iterate the stent geometry in CAD against the segmented model, simulate the fit, print the mold, cast the silicone, and deliver it bronchoscopically.

Each step is boring on its own. Together they collapse a design cycle that used to run in months into something that can meet a patient’s timeline.

What Clinicians Should Actually Ask

You don’t need to run the simulations to use the devices well. You do need to know enough about how they were built to ask sharp questions when a rep hands you a spec sheet or a case coordinator proposes a custom build.

• Source of the anatomy. Ask what imaging fed the model, when it was acquired, and whether the airway has changed since. A stent designed to a three-month-old CT is a stent designed to a three-month-old airway.
• Intended context of use. Find out what the simulation was meant to answer: fit, flow, or fatigue. A model validated for one question is not automatically valid for another.
• Failure modes on record. Custom does not mean forgiving. Ask about migration, granulation, and mucus plugging in the manufacturer’s own follow-up data, not just the launch paper.
• Revision pathway. If the device needs to be remade, how long does the loop take and who owns the source files? That answer decides how usable the technology is on your worst week, not your best one.

Staying current on this is part of the job, and the field is moving faster than most recertification cycles. If your next block of continuing education has room for it, a course on advanced airway devices or imaging-guided therapy is a better use of the hours than another repeat of a topic you already know cold.

Read more about CAD, product design and related technology at SolidSmack.com

Source: https://www.solidsmack.com/3d-cad-technology/from-screen-to-airway-how-cad-and-3d-simulation-are-rewriting-the-respiratory-device-playbook/